Please login to the form below

Not currently logged in

NanoValent promotes Mark Lewis to COO

He will also continue to manage the group’s business operations

NanoValent Mark LewisUK and US-based NanoValent Pharmaceuticals has promoted Mark Lewis to chief operating officer.

Lewis brings over 30 years of international commercial and operations expertise - gained primarily in the area of oncology - to the role, and first joined the early-stage oncology group in 2015.

He has worked at a number of pharmaceutical firms including Amersham International (now GE), Chiron (now Novartis) and Farmitalia (now Pfizer).

In addition to his pharmaceutical experience, Lewis also spent 10 years as a management consultant, working at Hill & Knowlton and Quintiles.

Most recently, Lewis served as managing director for Europe at SuperGen (now Otsuka Pharmaceutical) between 2006 and 2010, and was senior vice president of Ascalon Inc from 2010 until 2012.

8th August 2016

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...